Abstract
Introduction. In CV-1 cells, shuttling from cytoplasm to nucleus of the nuclear thyroid hormone receptor-01 (TB/31, TR) is shown in this report to be regulated by extracellular thyroid hormone at a hormone receptor on cell surface integrin av3. Methods. The receptor was introduced into cells as a GFP-TR1 chimera and intracellular movement of the receptor was monitored by confocal microscopy of cells treated with L-thyroxine (T 4). Results and Discussion. TR-GFP translocation in the presence ofT 4 requires activation of extracellular-regulated protein kinases 1/2 (ERK1/2). Inhibition of Tj-binding to av/33 with anti-av/33 or Arg-Gly-Asp (RGD) peptide blocks TfStimulated GFP-TR nuclear translocation, as do the hormone-binding inhibitor tetraiodothyroacetic acid (tet-rac) and the ERK1/2 inhibitor, PD98059. TR1 is an ERK1/2 substrate. Conclusions. Via a nongenomic mechanism initiated at plasma membrane integrin v3, T 2a-activated ERK1/2 and TR1 move transiently in an immunoprecipitable comphx to the nuclei of T 2a-treated cells.
Original language | English |
---|---|
Pages (from-to) | 31-42 |
Number of pages | 12 |
Journal | Endocrine Research |
Volume | 34 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - Mar 2009 |
Externally published | Yes |
Keywords
- Integrin αvβ3
- L-thyroxine
- Nongenomic Actions
- TRβ1 Transport
ASJC Scopus subject areas
- Endocrinology